Regarding post-resuscitation care and prognostication after successful return of spontaneous circulation (ROSC) in a 62-year-old woman resuscitated from out-of-hospital VF arrest, all of the following are true EXCEPT:

Explanation

## Post-Resuscitation Care & Prognostication After ROSC This question tests understanding of evidence-based prognostication and management after successful resuscitation. The stem asks which statement is **NOT true** or is misleading. ### Overview of Post-Resuscitation Prognostication **Key Point:** No single test or finding should be used in isolation to predict poor neurological outcome or guide withdrawal of care. A **multimodal approach** is required. ### Correct Statements (Options 0, 1, 3) #### Option 0 — Targeted Temperature Management (TTM) - Current evidence supports TTM at 32–36 °C for 24 hours in comatose post-arrest patients - Reduces cerebral metabolic rate and ischemic injury - Improves neurological outcomes and reduces mortality - Recommended by AHA/ERC guidelines for all comatose patients after ROSC #### Option 1 — Clinical Neurological Examination - Pupillary light reflex and corneal reflex assessed at **≥72 hours** post-arrest (not 24 hours, but the principle is correct) - Absence of both reflexes at ≥72 hours is associated with poor prognosis - However, early assessment (<24 h) is **not reliable** due to sedation and hypothermia - Must be reassessed after rewarming and sedation cessation #### Option 3 — EEG Findings - Burst suppression, generalized periodic discharges, and status epilepticus on EEG are associated with poor prognosis - **But EEG alone is not diagnostic** — must be interpreted in clinical context - Recommended as part of multimodal prognostication ### Why Option 2 Is INCORRECT (The Answer) **High-Yield:** Serum neuron-specific enolase (NSE) is **NOT** a reliable single-test predictor of poor outcome. **Problems with NSE as a Sole Prognostic Tool:** | Issue | Details | |---|---| | **Sensitivity** | Moderate (60–80%), not highly sensitive | | **Specificity** | Poor to moderate; elevated in many conditions (hemolysis, trauma, seizures) | | **Timing** | Levels peak at 24–48 h but can be elevated from non-neurological causes | | **Guideline Status** | NOT recommended as sole predictor; only as part of multimodal assessment | | **Clinical Use** | May support poor prognosis if very high (>33 μg/L) but cannot guide withdrawal alone | **Clinical Pearl:** Current guidelines (AHA 2019, ERC 2021) explicitly state that **no single test should be used in isolation** to predict poor outcome or guide withdrawal of care. NSE, if used, must be combined with clinical examination, imaging (CT/MRI), EEG, and somatosensory evoked potentials (SSEP). **Warning:** Using NSE alone to withdraw care is a **common pitfall** and violates current standards of prognostication. Families and clinicians may be falsely reassured or falsely pessimistic based on a single biomarker. ### Multimodal Prognostication Algorithm ```mermaid flowchart TD A[Post-ROSC Comatose Patient]:::outcome --> B[Initiate TTM 32-36°C]:::action B --> C[Optimize sedation/analgesia]:::action C --> D[Clinical exam at ≥72 hours post-rewarming]:::action D --> E{Absent pupil + corneal reflexes?}:::decision E -->|Yes| F[Poor prognosis indicator]:::outcome E -->|No| G[Continue assessment]:::action G --> H[EEG, SSEP, NSE, MRI/CT]:::action H --> I{Multimodal evidence of poor outcome?}:::decision I -->|Yes, consistent findings| J[Consider withdrawal after discussion]:::action I -->|No or conflicting| K[Continue intensive care, reassess]:::action ``` **Mnemonic for Prognostication Tools — SCENE:** - **S** — SSEP (somatosensory evoked potentials; bilateral absence = poor prognosis) - **C** — Clinical exam (pupil, corneal reflex at ≥72 h) - **E** — EEG (burst suppression, periodic discharges) - **N** — Neuroimaging (CT/MRI; diffuse injury = poor prognosis) - **E** — Enolase (NSE; very high levels supportive but NOT diagnostic alone)